NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $10,949,000 | +13.2% | 66,042 | -4.8% | 0.13% | +12.5% |
Q1 2021 | $9,676,000 | -65.5% | 69,363 | -57.2% | 0.11% | -66.4% |
Q4 2020 | $28,034,000 | +249.9% | 161,954 | -21.4% | 0.33% | +326.9% |
Q4 2018 | $8,013,000 | -31.8% | 206,053 | +0.0% | 0.08% | -20.4% |
Q3 2018 | $11,745,000 | -17.5% | 206,052 | +15.6% | 0.10% | -9.3% |
Q2 2018 | $14,236,000 | -16.3% | 178,287 | -9.2% | 0.11% | -15.6% |
Q1 2018 | $17,017,000 | +26.5% | 196,343 | +0.8% | 0.13% | +36.2% |
Q4 2017 | $13,449,000 | -30.8% | 194,803 | -8.9% | 0.09% | -32.4% |
Q3 2017 | $19,444,000 | +4.7% | 213,949 | -14.2% | 0.14% | -1.4% |
Q2 2017 | $18,568,000 | – | 249,470 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |